<SEC-DOCUMENT>0001096906-21-002587.txt : 20211026
<SEC-HEADER>0001096906-21-002587.hdr.sgml : 20211026
<ACCEPTANCE-DATETIME>20211026150222
ACCESSION NUMBER:		0001096906-21-002587
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20211026
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211026
DATE AS OF CHANGE:		20211026

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UTAH MEDICAL PRODUCTS INC
		CENTRAL INDEX KEY:			0000706698
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870342734
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12575
		FILM NUMBER:		211347890

	BUSINESS ADDRESS:	
		STREET 1:		7043 S 300 WEST
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8015661200
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>utmd-20211026.htm
<DESCRIPTION>UTAH MEDICAL PRODUCTS, INC. - FORM 8-K SEC FILING
<TEXT>
<XBRL>
<?xml version='1.0' encoding='us-ascii' standalone='no'?>
<html xmlns='http://www.w3.org/1999/xhtml' xmlns:xbrli='http://www.xbrl.org/2003/instance' xmlns:dei='http://xbrl.sec.gov/dei/2020-01-31' xmlns:i='http://www.xbrl.org/2003/instance' xmlns:xbrldi='http://xbrl.org/2006/xbrldi' xmlns:iso4217='http://www.xbrl.org/2003/iso4217' xmlns:ix='http://www.xbrl.org/2013/inlineXBRL' xmlns:ixt='http://www.xbrl.org/inlineXBRL/transformation/2015-02-26' xmlns:ixt-sec='http://www.sec.gov/inlineXBRL/transformation/2015-08-31' xmlns:utr='http://www.xbrl.org/2009/utr' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance'>
<head>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VFXC9N1U]. www.edgarsuite.com -->
<title>UTAH MEDICAL PRODUCTS, INC. - Form 8-K SEC filing</title>
<meta content='text/html; charset=UTF-8' http-equiv='Content-Type' />
</head>
<body>
<div style='display:none'>
<ix:header>
<ix:hidden>
<ix:nonNumeric name='dei:EntityCentralIndexKey' contextRef='D211026' id='fact1'>0000706698</ix:nonNumeric>
<ix:nonNumeric name='dei:AmendmentFlag' contextRef='D211026' id='fact2'>false</ix:nonNumeric>
</ix:hidden>
<ix:references>
<link:schemaRef xlink:arcrole='http://www.xbrl.org/2003/linkbase' xlink:href='utmd-20211026.xsd' xlink:type='simple'/>
</ix:references>
<ix:resources>
<i:context id='D211026'>
<i:entity>
<i:identifier scheme='http://www.sec.gov/CIK'>0000706698</i:identifier>
</i:entity>
<i:period>
<i:startDate>2021-10-26</i:startDate>
<i:endDate>2021-10-26</i:endDate>
</i:period>
</i:context>
</ix:resources>
</ix:header>
</div>
<div style='margin-left:72pt;width:468pt'><hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:14pt Times New Roman;margin:0;text-align:center'><b>UNITED STATES </b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
<p style='font:15pt Times New Roman;margin:0;text-align:center'><b>Washington, D.C. &#160;20549</b></p>
<p style='font:15pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>FORM <ix:nonNumeric name='dei:DocumentType' contextRef='D211026' escape='true'>8-K</ix:nonNumeric></b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'><b>CURRENT REPORT</b></p>
<p style='font:14pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:12pt Times New Roman;margin:0;text-align:center'><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>Date of Report (date of earliest event reported): &#160;<b><ix:nonNumeric name='dei:DocumentPeriodEndDate' contextRef='D211026' format='ixt:datemonthdayyearen'>October 26, 2021</ix:nonNumeric></b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;margin-right:72pt;text-align:justify'>&#160;</p>
<table style='border-collapse:collapse;width:468pt'><tr><td colspan='5' valign='top' style='width:468pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:14pt'><b><ix:nonNumeric name='dei:EntityRegistrantName' contextRef='D211026' escape='true'>UTAH MEDICAL PRODUCTS, INC.</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td colspan='5' valign='top' style='width:468pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Exact name of registrant as specified in its charter)</p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'><b><ix:nonNumeric name='dei:EntityIncorporationStateCountryCode' contextRef='D211026' format='ixt-sec:stateprovnameen'>Utah</ix:nonNumeric></b></p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:11pt'><b><ix:nonNumeric name='dei:EntityFileNumber' contextRef='D211026' escape='true'>000-12575</ix:nonNumeric></b></span></p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:11pt'><b><ix:nonNumeric name='dei:EntityTaxIdentificationNumber' contextRef='D211026' escape='true'>87-0342734</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(State or other jurisdiction of</p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Commission File Number)</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(IRS Employer</p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>incorporation or organization)</p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>Identification No.)</p>
</td></tr>
<tr><td valign='top' style='width:147.95pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.15pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b><ix:nonNumeric name='dei:EntityAddressAddressLine1' contextRef='D211026' escape='true'>7043 South 300 West</ix:nonNumeric></b></span></p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b><ix:nonNumeric name='dei:EntityAddressCityOrTown' contextRef='D211026' escape='true'>Midvale</ix:nonNumeric></b><b>, </b><b><ix:nonNumeric name='dei:EntityAddressStateOrProvince' contextRef='D211026' format='ixt-sec:stateprovnameen'>Utah</ix:nonNumeric></b><b> </b></span></p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b><ix:nonNumeric name='dei:EntityAddressPostalZipCode' contextRef='D211026' escape='true'>84047</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Address of principal executive offices)</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Zip code)</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:11pt Times New Roman;margin:0'>Registrant&#8217;s telephone number, including area code: &#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:10pt Times New Roman;margin:0;text-align:center'><span style='font-size:12pt'><b>Phone: </b><b>(</b><b><ix:nonNumeric name='dei:CityAreaCode' contextRef='D211026' escape='true'>801</ix:nonNumeric></b><b>) </b><b><ix:nonNumeric name='dei:LocalPhoneNumber' contextRef='D211026' escape='true'>566-1200</ix:nonNumeric></b></span></p>
</td></tr>
<tr><td colspan='3' valign='top' style='width:308pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.1pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:147.9pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td></tr>
<tr><td colspan='5' valign='top' style='width:468pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:12pt Times New Roman;margin:0;text-align:center'><b>n/a</b></p>
</td></tr>
<tr><td colspan='5' valign='top' style='width:468pt;padding-left:0.7pt;padding-right:0.7pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>(Former name or former address, if changed since last report)</p>
</td></tr>
</table>
<p style='font:11pt Times New Roman;margin:0;margin-right:72pt;text-align:justify'>&#160;</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</div>
<div style='margin-left:72pt'><table style='border-collapse:collapse'><tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:WrittenCommunications' contextRef='D211026' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:SolicitingMaterial' contextRef='D211026' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:PreCommencementTenderOffer' contextRef='D211026' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'><ix:nonNumeric name='dei:PreCommencementIssuerTenderOffer' contextRef='D211026' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:478.8pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</p>
</td></tr>
<tr><td valign='top' style='width:27.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:450.9pt'><p style='font:10pt Times New Roman;margin:0;text-align:right'>Emerging growth company <ix:nonNumeric name='dei:EntityEmergingGrowthCompany' contextRef='D211026' format='ixt-sec:boolballotbox'>&#9744;</ix:nonNumeric></p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:478.8pt'><p style='font:10pt Times New Roman;margin:0'>&#160;</p>
</td></tr>
<tr><td colspan='2' valign='top' style='width:478.8pt'><p style='font:10pt Times New Roman;margin:0'>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&#160;&#160;]</p>
</td></tr>
</table>
</div>
<div style='margin-left:72pt;width:468pt'><hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><hr style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'/><p style='line-height:0;margin:0'></p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:11pt Times New Roman;margin:0'><b>ITEM 2.02&#8212;RESULTS OF OPERATIONS AND FINANCIAL CONDITION</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;margin-left:72pt'>Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three months ended September 30, 2021 and forward-looking statements relating to 2021 and beyond as presented in a press release dated October 26, 2021. &#160;The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0'><b>ITEM 9.01&#8212;FINANCIAL STATEMENTS AND EXHIBITS</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>The following is filed as an exhibit to this report: &#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</div>
<div style='margin-left:72pt'><table style='border-collapse:collapse;width:476pt'><tr><td valign='top' style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:9pt Times New Roman;margin:0;text-align:center'><b>Exhibit</b></p>
<p style='font:9pt Times New Roman;margin:0;text-align:center'><b>Number*</b></p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:9pt Times New Roman;margin:0;text-align:center'><b>Title of Document</b></p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt;border-bottom:0.5pt solid #000000'><p style='font:9pt Times New Roman;margin:0;text-align:center'>&#160;</p>
<p style='font:9pt Times New Roman;margin:0;text-align:center'><b>Location</b></p>
</td></tr>
<tr><td valign='top' style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'><b>Item 99.1</b></p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'><span style='color:#0000FF;border-bottom:1px solid #0000FF'><a href='utah_ex99z1.htm' style='text-decoration:none'>Financial information for Utah Medical Products, Inc. for the three months ended September 30, 2021 and forward-looking statements relating to 2021 and beyond as presented in a press release dated October 26, 2021.</a></span></p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>This filing</p>
</td></tr>
<tr><td valign='top' style='width:59.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:center'>&#160;</p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:329.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0'>&#160;</p>
</td><td valign='top' style='width:12.5pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:61.75pt;padding-left:5.75pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
</table>
</div>
<div style='margin-left:72pt;width:468pt'><p style='font:11pt Times New Roman;margin:0;text-indent:-18pt;margin-left:18pt;text-align:justify'>_______________________________________</p>
<p style='font:9pt Times New Roman;margin-top:6pt;margin-bottom:0pt;margin-left:18pt;text-align:justify'><kbd style='position:absolute;font:9pt Times New Roman;margin-left:-18pt'>*</kbd>All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. &#160;</p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><hr style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'/><p style='line-height:0;margin:0'></p>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/><p style='font:11pt Times New Roman;margin:0;text-align:center'><b>SIGNATURES</b></p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
<table style='border-collapse:collapse;width:100%'><tr><td valign='top' style='width:48.84%'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:51.16%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'><b>UTAH MEDICAL PRODUCTS, INC.</b></p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:51.16%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:51.16%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td colspan='2' valign='top' style='width:51.16%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>Dated:  October 26, 2021</p>
</td><td valign='top' style='width:5.62%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>By:</p>
</td><td valign='top' style='width:45.54%;border-bottom:0.5pt solid #000000'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>/s/ Kevin L. Cornwell</p>
</td></tr>
<tr><td valign='top' style='width:48.84%'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:5.62%;padding-left:0.7pt;padding-right:5.75pt'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>&#160;</p>
</td><td valign='top' style='width:45.54%;border-top:0.5pt solid #000000'><p style='font:11pt Times New Roman;margin:0;text-align:justify'>Kevin L. Cornwell, Chief Executive Officer</p>
</td></tr>
</table>
<hr style='border:0;height:0;width:0;margin:14pt 0 0 0'/></div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>utah_ex99z1.htm
<DESCRIPTION>FINANCIAL INFORMATION
<TEXT>
<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VFXC9N1U]. www.edgarsuite.com -->
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:11pt Times New Roman;margin:0'><B>EXHIBIT 99.1</B></P>
<P align=center style='font:10pt Times New Roman;margin:0;margin-right:-6.3pt'><B>UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2021</B></P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:50%><P style='font:11pt Times New Roman;margin:0'>Contact: Crystal Rios (801) 566-1200</P>
</TD><TD valign=top style=width:50%><P align=right style='font:11pt Times New Roman;margin:0'>October 26, 2021</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Salt Lake City, Utah &#8211;&nbsp;The third calendar quarter (3Q) of 2021 financial results continued to demonstrate Utah Medical Products, Inc.&#8217;s (Nasdaq: UTMD&#8217;s) recovery after a time when there were restrictions on so-called nonessential medical procedures during the COVID-19 pandemic. Because of the unusual dip in 2020 demand for its devices, UTMD management continues to report quarterly income statement results compared to the same periods not only in 2021 compared to 2020, but also compared to 2019. The Company is exceeding its stated objective in 2021 to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; &#163;&nbsp;or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and &#8364;&nbsp;or EUR = Euros. Currency amounts throughout this report are in thousands, except per share amounts and where noted. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Overview of Results</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>The following summary comparison of 3Q and first nine months (9M) of 2021 with 3Q and 9M 2020 income statement measures demonstrates UTMD&#8217;s excellent recovery, despite many new challenges:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:80%><TR><TD valign=top style=width:38.04%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:1.84%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:27.72%><P align=center style='font:11pt Times New Roman;margin:0'>3Q</P>
</TD><TD valign=top style=width:0.1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:1.82%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:30.48%><P align=center style='font:11pt Times New Roman;margin:0'>9M</P>
</TD></TR>
<TR><TD valign=top style='width:38.04%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>2021 to 2020 Comparison</P>
</TD><TD valign=top style=width:1.84%><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style='width:27.72%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(July &#8211;&nbsp;September)</P>
</TD><TD valign=top style=width:0.1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:1.82%><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style='width:30.48%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(January-September)</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:38.04%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Revenues (Sales):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.84%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:27.72%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 20%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:0.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.82%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:30.48%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 20%</P>
</TD></TR>
<TR><TD valign=top style=width:38.04%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit (GP):</P>
</TD><TD valign=top style=width:1.84%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:27.72%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 24%</P>
</TD><TD valign=top style=width:0.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:1.82%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:30.48%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 25%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:38.04%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income (OI):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.84%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:27.72%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 42%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:0.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.82%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.48%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 46%</P>
</TD></TR>
<TR><TD valign=top style=width:38.04%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Income Before Tax (EBT):</P>
</TD><TD valign=top style=width:1.84%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:27.72%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 44%</P>
</TD><TD valign=top style=width:0.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:1.82%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:30.48%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 45%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:38.04%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income (NI):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.84%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:27.72%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 43%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:0.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.82%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:30.48%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 44%</P>
</TD></TR>
<TR><TD valign=top style=width:38.04%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>Earnings Per Share (EPS):</P>
</TD><TD valign=top style=width:1.84%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&#160;&#160;</P>
</TD><TD valign=top style=width:27.72%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>+ 43%</P>
</TD><TD valign=top style=width:0.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&#160;&#160;</P>
</TD><TD valign=top style=width:1.82%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&#160;&#160;</P>
</TD><TD valign=top style=width:30.48%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>+ 45%</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>As longer-term UTMD stockholders appreciate, the above dramatic increases resulted from comparing 2021 financial results with the former depressed COVID-19 pandemic year in which so-called &#8220;nonessential&#8221; medical procedures using UTMD&#8217;s devices were restricted by government fiat. &nbsp;Perhaps the following comparison of 3Q and first nine months (9M) of 2021 with 3Q and 9M 2019, prior to the 2020 pandemic year, might be more meaningful:</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:80%><TR><TD valign=top style=width:38.7%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:1.18%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:28.1%><P align=center style='font:11pt Times New Roman;margin:0'>3Q</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:31.02%><P align=center style='font:11pt Times New Roman;margin:0'>9M</P>
</TD></TR>
<TR><TD valign=top style='width:38.7%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>2021 to 2019 Comparison</P>
</TD><TD valign=top style=width:1.18%><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style='width:28.1%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(July &#8211;&nbsp;September)</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:31.02%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(January-September)</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:38.7%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Revenues (Sales):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:28.1%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 1%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:31.02%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 3%</P>
</TD></TR>
<TR><TD valign=top style=width:38.7%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit (GP):</P>
</TD><TD valign=top style=width:1.18%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:28.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 9%</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:31.02%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 5%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:38.7%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income (OI):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:28.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 17%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:31.02%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 6%</P>
</TD></TR>
<TR><TD valign=top style=width:38.7%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Income Before Tax (EBT):</P>
</TD><TD valign=top style=width:1.18%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:28.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 16%</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:31.02%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 6%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:38.7%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income (NI):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:28.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 14%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:31.02%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 3%</P>
</TD></TR>
<TR><TD valign=top style=width:38.7%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>Earnings Per Share (EPS):</P>
</TD><TD valign=top style=width:1.18%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&#160;&#160;</P>
</TD><TD valign=top style=width:28.1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>+ 16%</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
</TD><TD valign=top style=width:31.02%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>+ 5%</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>The above increases in NI and EPS according to U.S. Generally Accepted Accounting Principles (US GAAP) in both 9M 2021 and 9M 2020 (but <FONT style='border-bottom:1px solid #000000'>not</FONT> in 3Q 2021 or 3Q 2020, nor in 3Q 2019 and 9M 2019) were affected by long term deferred tax liability (DTL) increases on the balance of Femcare identifiable intangible assets (IIA) due to future changes enacted in UK tax rates. As stockholders may remember, the DTL was initiated as of the 2011 acquisition of Femcare because the expense from amortizing Femcare IIA, most of which is occurring over a fifteen year time span from the acquisition date, is not tax-deductible in the UK. According to US GAAP, the future tax impact of a change in DTL must be recognized in the quarter in which a tax law change is enacted. In 2Q 2020, a $225 increase in deferred UK </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'><FONT style=font-size:11pt>taxes over the next six years occurred because the UK decided to not reduce its corporate income tax rate from 19% to 17% beginning in 2Q 2020, as was previously enacted. This year in 2Q 2021, another $390 increase in DTL over the remaining five years occurred because in June 2021, UK parliament ratified the Finance Minister&#8217;s plan to increase the UK corporate income tax rate from 19% to 25% beginning on April 1, 2023, which affects the deferred taxes for IIA to be amortized after April 1, 2023 until fully amortized as of 1Q 2026.</FONT></P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>UTMD management believes that the presentation of results excluding the unfavorable deferred tax liability adjustments to its 9M 2021 and 9M 2020 income tax provisions provide meaningful supplemental information to both management and investors that is more clearly indicative of UTMD&#8217;s operating results. The non-US GAAP exclusion only affects Net Income and Earnings Per Share.</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>Excluding the 2Q 2020 and 2Q 2021 deferred tax liability increases and resulting &#8220;one-time&#8221; tax provision increases due to the UK income tax rate changes, the resulting non-US GAAP 9M NI and EPS changes follow: </P>
<TABLE align=center style=border-collapse:collapse;width:60%><TR><TD valign=top style=width:50.36%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:49.64%><P align=center style='font:11pt Times New Roman;margin:0'>9M 2021 to 9M 2020</P>
</TD></TR>
<TR><TD valign=top style=width:50.36%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:49.64%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(January-September)</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:50.36%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>NI (non-US GAAP):</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:49.64%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 45%</P>
</TD></TR>
<TR><TD valign=top style=width:50.36%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>EPS (non-US GAAP):</P>
</TD><TD valign=top style=width:49.64%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>+ 46%</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>In brief, the 3Q and 9M 2021 financial results continue to confirm that, after surviving a depression in its business in 2020, UTMD is back on track, notwithstanding possible future restrictions on healthcare which benefits from the use of UTMD&#8217;s medical devices, or other consequences of recent government policies that are having a negative impact on the free market, medical device industry and small businesses in particular.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Sales in all product categories and almost all distribution channels were up substantially in 3Q and 9M 2021 compared to the same periods in 2020. Sales invoiced in foreign currencies, which represented 27% of total consolidated sales (when expressed in USD) during both 3Q 2021 and 9M 2021, were helped by a weaker USD. &nbsp;Consolidated USD sales in 3Q were 0.7% higher, and in 9M 2021 were 1.9% higher, to that which would have resulted using the same foreign currency exchange (FX) rates as in the prior year&#8217;s same periods (&#8220;constant currency sales&#8221;). &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Profit margins in 3Q and 9M 2021 compared to 3Q and 9M 2020 follow:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:36.54%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
</TD><TD valign=top style='width:10%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>3Q 2021<BR>(Jul &#8211;&nbsp;Sep)</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
</TD><TD valign=top style='width:12%;border-bottom:0.5pt solid #000000;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>3Q 2020<BR>(Jul &#8211;&nbsp;Sep)</P>
</TD><TD valign=top style='width:1%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
</TD><TD valign=top style='width:12%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>9M 2021<BR>(Jan &#8211;&nbsp;Sep)</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>&nbsp;</P>
</TD><TD valign=top style='width:12%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.5pt'>9M 2020<BR>(Jan &#8211;&nbsp;Sep)</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:36.54%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Gross Profit Margin (GP/ sales):</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&#160;&#160;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:10%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>64.2%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12%;border-top:0.5pt solid #000000;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>62.0%</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:1%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>63.1%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>60.6%</P>
</TD></TR>
<TR><TD valign=top style=width:45%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Operating Income Margin (OI/ sales):</P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:10%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>40.6%</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style='width:12%;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>34.2%</P>
</TD><TD valign=top style='width:1%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:12%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>38.0%</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style=width:12%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>31.3%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:45%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>Net Income Margin (US GAAP)</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:10%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>33.5%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12%;border-bottom:0.5pt solid #000000;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>28.0%</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:1%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>29.5%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:12%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>24.5%</P>
</TD></TR>
<TR><TD valign=top style='width:45%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'><I>Net Income Margin (Non-US GAAP, B4 DTL Adj):</I></P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'><I>&#160;&#160;</I></P>
</TD><TD valign=top style='width:10%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'><I>33.5%</I></P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style='width:12%;border-top:0.5pt solid #000000;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'><I>28.0%</I></P>
</TD><TD valign=top style='width:1%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style='width:12%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'><I>30.6%</I></P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'>&nbsp;</P>
</TD><TD valign=top style='width:12%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0;margin-right:-6.3pt'><I>25.2%</I></P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Note: &nbsp;The Net Income Margin is NI, after subtracting a provision for taxes, divided by sales.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>In 2020, because the Company did not make drastic cuts to its operating overheads to try to match the lower sales activity, profit margins suffered relative to UTMD&#8217;s performance in prior years, but still remained very solid in regard to UTMD&#8217;s ability to remain viable during the pandemic. The decision to not cut back was based on management&#8217;s belief that most overhead expenses represented critical resources needed to support the business as it was expected to recover, together with the comfort of UTMD&#8217;s cash reserves. &nbsp;Profit margins in 2021 have returned to levels more consistent with longer term management expectations. </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'>UTMD&#8217;s September 30, 2021 Balance Sheet, in the absence of debt, continued to strengthen. Ending Cash and Investments were $64.3 million on September 30, 2021 compared to $51.6 million on December 31, 2020, after paying $3.1 million in cash dividends to stockholders during 9M 2021. &nbsp;UTMD&#8217;s cash balance increased $18 million, or $4.94/ outstanding share at September 30, 2021 from one year earlier, after paying $1.14/ share during that same twelve month period. Stockholders&#8217; Equity (SE) increased $7.2 million in the nine month period from December 31, 2020 despite the fact that dividends reduce SE. &nbsp;Compared to September 30, 2020, one year earlier, SE increased $11.6 million. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Foreign currency exchange (FX) rates for Balance Sheet purposes are the applicable rates at the end of each reporting period. The FX rates from the applicable foreign currency to USD for assets and liabilities at the end of 3Q 2021 compared to the end of calendar year 2020 and the end of 3Q 2020 follow:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:10.34%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:15.5%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9-30-21</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:17.5%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>12-31-20</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:14.6%;border-bottom:0.5pt solid #000000;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>Change</P>
</TD><TD valign=top style='width:2.38%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:15.5%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9-30-20</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:14.6%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>Change</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:10.34%><P style='font:11pt Times New Roman;margin:0'>GBP</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.5%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1.34676</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.5%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1.36631</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.6%;border-top:0.5pt solid #000000;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(1.4%)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:2.38%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.5%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1.29175</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.6%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>4.3%</P>
</TD></TR>
<TR><TD valign=top style=width:10.34%><P style='font:11pt Times New Roman;margin:0'>EUR</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.5%><P align=center style='font:11pt Times New Roman;margin:0'>1.15770</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:17.5%><P align=center style='font:11pt Times New Roman;margin:0'>1.22281</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:14.6%;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(5.3%)</P>
</TD><TD valign=top style='width:2.38%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.5%><P align=center style='font:11pt Times New Roman;margin:0'>1.17238</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:14.6%><P align=center style='font:11pt Times New Roman;margin:0'>(1.3%)</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:10.34%><P style='font:11pt Times New Roman;margin:0'>AUD</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.5%><P align=center style='font:11pt Times New Roman;margin:0'>0.72284</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:17.5%><P align=center style='font:11pt Times New Roman;margin:0'>0.77079</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:14.6%;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>(6.2%)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:2.38%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.5%><P align=center style='font:11pt Times New Roman;margin:0'>0.71614</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.6%><P align=center style='font:11pt Times New Roman;margin:0'>0.9%</P>
</TD></TR>
<TR><TD valign=top style=width:10.34%><P style='font:11pt Times New Roman;margin:0'>CAD</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style=width:15.5%><P align=center style='font:11pt Times New Roman;margin:0'>0.78908</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style=width:17.5%><P align=center style='font:11pt Times New Roman;margin:0'>0.78406</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style='width:14.6%;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>0.6%</P>
</TD><TD valign=top style='width:2.38%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style=width:15.5%><P align=center style='font:11pt Times New Roman;margin:0'>0.75056</P>
</TD><TD valign=top style=width:2.38%><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style=width:14.6%><P align=center style='font:11pt Times New Roman;margin:0'>5.1%</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Revenues (sales)</FONT> -<FONT style='border-bottom:1px solid #000000'>3Q 2021</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>Total consolidated 3Q 2021 UTMD worldwide (WW) sales were $2,094 (+20.0%) higher than in 3Q 2020. Constant currency sales were $2,006 (+19.1%) higher. U.S. domestic sales were 11% higher and outside the U.S. (OUS) sales were 37% higher. Without the help of a weaker USD in converting foreign currency sales, OUS sales were 34% higher (i.e. constant currency sales). In 3Q 2021, after lagging in 1H 2021 improvement, OUS sales began to catch up with U.S. domestic sales. Because of the relatively short span of time, results for any given three month period in comparison with a previous three month period may not be indicative of comparative results for the year as a whole. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Domestic U.S. sales in 3Q 2021 were $7,749 compared to $6,950 in 3Q 2020. &nbsp;Domestic sales are invoiced in USD and not subject to FX rate fluctuations. The components of domestic sales include 1) &#8220;direct other device sales&#8221; of UTMD&#8217;s medical devices to user facilities (and med/surg stocking distributors for hospitals), excluding Filshie device sales, 2) &#8220;OEM sales&#8221; of components and other products manufactured by UTMD for other medical device and non-medical device companies, and 3) &#8220;direct Filshie device sales&#8221;. UTMD separates Filshie device sales from other medical device sales direct to medical facilities because of their significance, and the acquisition history. Direct other device sales, representing 48% of total domestic sales, were $277 (+8%) higher in 3Q 2021 than in 3Q 2020. OEM sales, representing 32% of total domestic sales, were $704 (+40%) higher. Direct Filshie device sales, representing 20% of total domestic sales, were $182 (10%) lower in 3Q 2021 compared to 3Q 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>OUS sales in 3Q 2021 were 37% higher at $4,823 compared to $3,528 in 3Q 2020. The increase in USD-denominated OUS sales was enhanced as a result of a weaker USD which added $88 to OUS sales that were invoiced in GBP, EUR, AUD and CAD foreign currencies (in constant currency terms). &nbsp;&#8220;Constant currency&#8221; sales means exchanging foreign currency sales into USD-denominated sales at the same FX rate as was in the previous period of time being compared. FX rates for income statement purposes are transaction-weighted averages. The average FX rates from the applicable foreign currency to USD during 3Q 2021 and 3Q 2020 for revenue purposes follow:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:80%><TR><TD valign=top style=width:15.86%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:25.4%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2021</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:25.4%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2020</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:22.38%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>Change</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:15.86%><P style='font:11pt Times New Roman;margin:0'>GBP</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:25.4%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1.3785</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:25.4%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1.2948</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:22.38%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>+ 6.5%</P>
</TD></TR>
<TR><TD valign=top style=width:15.86%><P style='font:11pt Times New Roman;margin:0'>EUR</P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:25.4%><P align=center style='font:11pt Times New Roman;margin:0'>1.1793</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:25.4%><P align=center style='font:11pt Times New Roman;margin:0'>1.1729</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:22.38%><P align=center style='font:11pt Times New Roman;margin:0'>+ 0.6%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:15.86%><P style='font:11pt Times New Roman;margin:0'>AUD</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25.4%><P align=center style='font:11pt Times New Roman;margin:0'>0.7348</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25.4%><P align=center style='font:11pt Times New Roman;margin:0'>0.7144</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:22.38%><P align=center style='font:11pt Times New Roman;margin:0'>+ 2.9%</P>
</TD></TR>
<TR><TD valign=top style=width:15.86%><P style='font:11pt Times New Roman;margin:0'>CAD</P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style=width:25.4%><P align=center style='font:11pt Times New Roman;margin:0'>0.7941</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:25.4%><P align=center style='font:11pt Times New Roman;margin:0'>0.7513</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:22.38%><P align=center style='font:11pt Times New Roman;margin:0'>+ 5.7%</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'>The weighted average favorable impact on 3Q 2021 foreign currency OUS sales was 2.7%, increasing reported USD sales by $88 relative to the same foreign currency sales in 3Q 2020. &nbsp;In constant currency terms, foreign currency sales in 3Q 2021 were 48% higher than in 3Q 2020. The portion of OUS sales invoiced in foreign currencies in USD terms were 27% of total consolidated 3Q 2021 sales compared to 21% in 3Q 2020. &nbsp;&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>OUS sales invoiced in foreign currencies are due to direct end-user sales in Ireland, the UK, France, Canada, Australia and New Zealand, and to shipments to OUS distributors of products manufactured by UTMD subsidiaries in Ireland and the UK. &nbsp;Export sales from the U.S. to OUS distributors are invoiced in USD. &nbsp;Direct to end-user OUS 3Q 2021 sales in USD terms were 9% higher in Ireland, 8% lower in Canada, 4% higher in France and 38% higher in the UK than in 3Q 2020. Direct to end-user sales in Australia, which included New Zealand in 3Q 2021 but not in 3Q 2020, were 23% higher. Sales to OUS distributors were 56% higher in 3Q 2021 than in 3Q 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Sales</FONT> -<FONT style='border-bottom:1px solid #000000'>9M 2021</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>Total consolidated 9M 2021 UTMD worldwide (WW) sales were $5,972 (+19.8%) higher than in 9M 2020. Constant currency sales were $5,303 (+17.6%) higher than in 9M 2020. U.S. domestic sales were 19% higher and OUS sales were 21% higher. Without the help of a weaker USD in converting foreign currency sales, OUS sales were 15% higher.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Domestic U.S. sales in 9M 2021 were $22,555 compared to $18,906 in 9M 2020. &nbsp;Direct other device sales, representing 48% of total domestic sales, were $1,229 (+13%) higher in 9M 2021 than in 9M 2020. OEM sales, representing 31% of total domestic sales, were $2,350 (+50%) higher. Direct Filshie device sales, representing 21% of total domestic sales, were $69 (+2%) higher in 9M 2021 compared to 9M 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>OUS sales in 9M 2021 were 21% higher at $13,585 compared to $11,262 in 9M 2020. The increase in USD-denominated OUS sales was enhanced as a result of a weaker USD which added $669 to OUS sales that were invoiced in GBP, EUR, AUD and CAD foreign currencies (in constant currency terms). &nbsp;FX rates for income statement purposes are transaction-weighted averages. The weighted-average FX rates from the applicable foreign currency to USD during 9M 2021 and 9M 2020 for revenue purposes follow:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:80%><TR><TD valign=top style=width:15.38%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:25.82%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2021</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:25.82%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2020</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style='width:22.34%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>Change</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:15.38%><P style='font:11pt Times New Roman;margin:0'>GBP</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:25.82%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1.3860</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:25.82%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>1.2793</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:22.34%;border-top:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>+ 8.3%</P>
</TD></TR>
<TR><TD valign=top style=width:15.38%><P style='font:11pt Times New Roman;margin:0'>EUR</P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:25.82%><P align=center style='font:11pt Times New Roman;margin:0'>1.1957</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:25.82%><P align=center style='font:11pt Times New Roman;margin:0'>1.1276</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:22.34%><P align=center style='font:11pt Times New Roman;margin:0'>+ 6.0%</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:15.38%><P style='font:11pt Times New Roman;margin:0'>AUD</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25.82%><P align=center style='font:11pt Times New Roman;margin:0'>0.7584</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:25.82%><P align=center style='font:11pt Times New Roman;margin:0'>0.6773</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:22.34%><P align=center style='font:11pt Times New Roman;margin:0'>+12.0%</P>
</TD></TR>
<TR><TD valign=top style=width:15.38%><P style='font:11pt Times New Roman;margin:0'>CAD</P>
</TD><TD valign=top style=width:1%><P style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=top style=width:25.82%><P align=center style='font:11pt Times New Roman;margin:0'>0.7985</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:25.82%><P align=center style='font:11pt Times New Roman;margin:0'>0.7449</P>
</TD><TD valign=top style=width:1%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:22.34%><P align=center style='font:11pt Times New Roman;margin:0'>+ 7.2%</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The weighted-average favorable impact on 9M 2021 foreign currency OUS sales was 7.4%, increasing reported USD sales by $669 relative to the same foreign currency sales in 9M 2020. &nbsp;In constant currency terms, OUS sales in 9M 2021 were 14.7% higher than in 9M 2020. The portion of OUS sales invoiced in foreign currencies in USD terms was 27% of total consolidated 9M 2021 sales compared to 21% in 9M 2020. Direct to end-user OUS 9M 2021 sales in USD terms were 20% higher in Ireland, 2% higher in Canada, 19% higher in France and 24% higher in the UK. &nbsp;Direct to end-user sales in Australia, which included New Zealand in 9M 2021 but not in 9M 2020, were 29% higher. Sales to OUS distributors were 22% higher in 9M 2021 than in 9M 2020. </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Gross Profit (GP)</FONT> </P>
<P style='font:11pt Times New Roman;margin:0'>GP results from subtracting the costs of manufacturing, quality assurance and receiving materials from suppliers. UTMD&#8217;s GP was $1,576 (+24.3%) higher in 3Q 2021 than in 3Q 2020, and $4,522 (+24.7%) higher in 9M 2021 than in 9M 2020. &nbsp;The primary contribution to an expanded GP Margin (GPM) was much greater dilution of fixed manufacturing overhead costs by 20% higher sales in both 3Q 2021 and 9M 2021. The greater percentage increase in GP than in sales is due to the ability to leverage fixed costs. Incremental direct labor costs did increase as a result of inflationary pressure on wages and competition for a limited number of people currently seeking work. Also during 3Q 2021, UTMD continued to experience double-digit percentage cost increases in a number of raw materials, as well as in the freight cost to receive the materials. The growing administrative burden of compliance with regulatory requirements, particularly OUS, continues to pressure UTMD&#8217;s GPM. Managing variable manufacturing costs will continue to be a significant challenge. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Operating Income (OI)</FONT> </P>
<P style='font:11pt Times New Roman;margin:0'>OI results from subtracting Operating Expenses (OE) from GP. After subtracting OE from substantially higher 3Q and 9M 2021 GP, OI in 3Q 2021 was $5,098 compared to $3,588 in 3Q 2020, an increase of 42.1%, and was $13,750 in 9M 2021 compared to $9,428 in 9M 2020, an increase of 45.8%. Despite OE in USD being slightly higher in 2021 than in the same 2020 time periods, as shown in the table below, the period-to-same-period increases in 2021 GP were further leveraged as a result of substantially better OE absorption (lower percentage of sales). </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>OE are comprised of Sales and Marketing (S&amp;M) expenses, General and Administrative (G&amp;A) expenses and Product Development (R&amp;D) expenses. The following table summarizes OE in 3Q and 9M 2021 compared to the same periods in 2020 by OE category:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style='width:13.16%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>OE <BR>Category</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.8%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2021</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <BR>sales</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.8%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2020</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-bottom:0.5pt solid #000000;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <BR>sales</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.2%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2021</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <BR>sales</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.2%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2020</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <BR>sales</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style='width:13.16%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>S&amp;M:</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.8%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:44pt'>324</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>2.6</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.8%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:44pt'>352</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.2%;border-top:0.5pt solid #000000;border-right:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>3.4</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:1.26%;border-left:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:11.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>1,071</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>3.0</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:11.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>1,195</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>4.0</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style=width:13.16%><P style='font:11pt Times New Roman;margin:0'>G&amp;A:</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.8%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:44pt'>2,524</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:8.2%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>20.1</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.8%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:44pt'>2,432</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-right:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>23.2</KBD>&nbsp;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:11.2%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>7,598</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:8.2%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>21.0</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:11.2%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>7,285</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:8.2%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>24.2</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style='width:13.16%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>R&amp;D:</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.8%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:44pt'>126</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.2%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>1.0</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.8%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:44pt'>125</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.2%;border-bottom:0.5pt solid #000000;border-right:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>1.2</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:1.26%;border-left:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:11.2%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>385</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.2%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>1.1</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:11.2%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>375</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.2%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>1.2</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style='width:13.16%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>Total OE:</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=bottom style='width:10.8%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:44pt'>2,974</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>23.7</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.8%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:44pt'>2,909</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-top:0.5pt solid #000000;border-right:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>27.8</KBD>&nbsp;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>9,054</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>25.1</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>8,855</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:31pt'>29.4</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Although a weaker USD helped increase consolidated USD sales in 2021, it also helped increase the USD-denominated OE of UTMD&#8217;s foreign subsidiaries by $49 in 3Q 2021 and $221 in 9M 2021. The following table summarizes &#8220;constant currency&#8221; OE in 3Q and 9M 2021 compared to the same periods in 2020 by OE category:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style='width:13.2%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>OE<BR>Category</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:18.52%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2021<BR>const FX</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:5.88%;border-right:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.75pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.74%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2020</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:4.9%;border-right:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:1.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:18.94%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2021 <BR>const FX</P>
</TD><TD valign=bottom style=width:1.26%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:6.28%;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:9.16%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2020</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:4.34%><P style='font:11pt Times New Roman;margin:0'>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style='width:13.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>S&amp;M:</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:18.52%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:79pt'>321</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:5.88%;border-right:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:1.26%;border-left:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.74%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:4pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>352</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:4.9%;border-right:1.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:1.26%;border-left:1.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:18.94%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:82pt'>1,049</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:6.28%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:1.26%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:9.16%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:4pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:39pt'>1,195</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:4.34%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style=width:13.2%><P style='font:11pt Times New Roman;margin:0'>G&amp;A:</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:18.52%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:79pt'>2,478</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:5.88%;border-right:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:8.74%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>2,432</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:4.9%;border-right:1.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:1.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:18.94%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:82pt'>7,400</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:6.28%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:9.16%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:39pt'>7,285</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:4.34%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style='width:13.2%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>R&amp;D:</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:18.52%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:79pt'>126</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:5.88%;border-right:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:1.26%;border-left:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.74%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>125</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:4.9%;border-right:1.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:1.26%;border-left:1.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:18.94%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:82pt'>384</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:6.28%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:1.26%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:9.16%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:39pt'>375</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:4.34%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style='width:13.2%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>Total OE:</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=bottom style='width:18.52%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:79pt'>2,925</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:5.88%;border-right:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.75pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.74%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>2,909</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:4.9%;border-right:1.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:1.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:18.94%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:82pt'>8,833</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:6.28%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:1.26%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:9.16%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:39pt'>8,855</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.26%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:4.34%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>In other words, 9M 2021 OE converted to USD at the same FX rate were actually somewhat lower than in 9M 2020. &nbsp;Holding OE constant while dramatically increasing revenues with a higher GPM had a huge favorable impact on OI.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The change in FX rates increased 3Q 2021 OUS S&amp;M expense by $3, and 9M 2021 OUS S&amp;M expense by $23. The lower constant currency S&amp;M expenses were due primarily to a reduction of one sales representative in the U.S.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'>A division of G&amp;A expenses by location follows. G&amp;A expenses include non-cash expenses from the amortization of IIA associated with the Filshie Clip System, which is also separated out below:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style='width:18.72%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>G&amp;A Exp <BR>Category</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:8.82%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2021</P>
</TD><TD valign=bottom style=width:2.46%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:7.68%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <BR>sales</P>
</TD><TD valign=bottom style=width:1.18%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.1%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2020</P>
</TD><TD valign=bottom style=width:1.18%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:7.68%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <BR>sales</P>
</TD><TD valign=bottom style=width:1.18%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.48%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2021</P>
</TD><TD valign=bottom style=width:1.18%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:7.68%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <BR>sales</P>
</TD><TD valign=bottom style=width:1.18%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.48%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2020</P>
</TD><TD valign=bottom style=width:1.18%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:7.64%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>% of <BR>sales</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style='width:18.72%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>IIA Amort- UK:</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.82%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:4pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>548</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:2.46%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:7.68%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>4.4</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.1%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:6pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:41pt'>516</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:7.68%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>4.9</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.48%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>1,654</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:7.68%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>4.6</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.48%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>1,523</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:7.64%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>5.0</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style=width:18.72%><P style='font:11pt Times New Roman;margin:0'>IIA Amort&#8211; CSI:</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:8.82%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>1,105</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:2.46%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>8.8</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.1%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:41pt'>1,105</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>10.5</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>3,316</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>9.2</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>3,316</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.64%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>11.0</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style=width:18.72%><P style='font:11pt Times New Roman;margin:0'>Other&#8211; UK:</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:8.82%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>158</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:2.46%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.1%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:41pt'>158</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>470</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>451</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.64%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style=width:18.72%><P style='font:11pt Times New Roman;margin:0'>Other&#8211; US:</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:8.82%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>550</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:2.46%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.1%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:41pt'>510</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>1,663</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>1,564</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.64%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style=width:18.72%><P style='font:11pt Times New Roman;margin:0'>IRE:</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:8.82%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>74</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:2.46%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.1%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:41pt'>72</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>235</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>198</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.64%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style=width:18.72%><P style='font:11pt Times New Roman;margin:0'>AUS:</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:8.82%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>48</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:2.46%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.1%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:41pt'>38</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>136</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.68%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>126</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:7.64%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style='width:18.72%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>CAN:</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:8.82%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>41</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:2.46%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:7.68%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.1%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:41pt'>33</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:7.68%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.48%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>124</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:7.68%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.48%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>106</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:7.64%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style='width:18.72%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>Total G&amp;A:</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&#160;&#160;</P>
</TD><TD valign=bottom style='width:8.82%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:37pt'>2,524</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:2.46%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:7.68%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>20.1</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.1%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:41pt'>2,432</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:7.68%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>23.2</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.48%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>7,598</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:7.68%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>21.0</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.48%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:42pt'>7,284</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:1.18%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:7.64%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:29pt'>24.1</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>About two-thirds of G&amp;A expenses in all periods above were from the non-cash expense of amortizing IIA related to the Filshie Clip System. OUS G&amp;A expenses were $869 in 3Q 2021 compared to $817 in 3Q 2020. OUS G&amp;A expenses were $2,619 in 9M 2021 compared to $2,405 in 9M 2020. &nbsp;The table below identifies constant currency OUS G&amp;A expenses for 3Q and 9M 2021 compared to the same periods in 2020:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=bottom style='width:26%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>G&amp;A Exp<BR>Category</P>
</TD><TD valign=top style=width:2.9%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.1%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2021 <BR>const FX</P>
</TD><TD valign=bottom style=width:7.4%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.76%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>3Q 2020</P>
</TD><TD valign=bottom style=width:6.8%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.76%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2021 <BR>const FX</P>
</TD><TD valign=bottom style=width:6.8%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.76%;border-bottom:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'>9M 2020</P>
</TD><TD valign=bottom style=width:6.74%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style='width:26%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>IIA Amort- UK:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.9%><P align=right style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:11.1%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>515</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.4%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.76%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>516</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.76%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>1,528</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.76%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>1,524</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.74%><P align=center style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style=width:26%><P style='font:11pt Times New Roman;margin:0'>Other&#8211; UK:</P>
</TD><TD valign=top style=width:2.9%><P align=right style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:11.1%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>149</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:7.4%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>158</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>434</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>451</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.74%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style=width:26%><P style='font:11pt Times New Roman;margin:0'>IRE:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.9%><P align=right style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:11.1%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>74</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.4%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>72</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>222</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>198</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.74%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style=width:26%><P style='font:11pt Times New Roman;margin:0'>AUS:</P>
</TD><TD valign=top style=width:2.9%><P align=right style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:11.1%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>47</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:7.4%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>38</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>122</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:10.76%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>126</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.74%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom bgcolor=#CCEEFF style='width:26%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>CAN:</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:2.9%><P align=right style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:11.1%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>38</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:7.4%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.76%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>33</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.76%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>116</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style='width:10.76%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>106</KBD>&nbsp;</P>
</TD><TD valign=bottom bgcolor=#CCEEFF style=width:6.74%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=bottom style='width:26%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>Total G&amp;A:</P>
</TD><TD valign=top style=width:2.9%><P align=right style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.1%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:45pt'>823</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:7.4%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.76%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>817</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.76%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>2,422</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.8%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:10.76%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:43pt'>2,405</KBD>&nbsp;</P>
</TD><TD valign=bottom style=width:6.74%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Period to period product development (R&amp;D) expenses varied slightly depending on specific project costs. Since almost all R&amp;D is being carried out in the U.S., there was negligible FX rate impact. &nbsp; </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Income Before Tax (EBT)</FONT> </P>
<P style='font:11pt Times New Roman;margin:0'>EBT results from subtracting net non-operating expense (NOE) or adding net non-operating income (NOI) from or to, as applicable, OI. &nbsp;Consolidated 3Q 2021 EBT was $5,157 (41.0% of sales) compared to $3,588 (34.2% of sales) in 3Q 2020. Consolidated 9M 2021 EBT was $13,880 (38.4% of sales) compared to $9,553 (31.7% of sales) in 9M 2020.  &nbsp;&nbsp;&nbsp;&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>NOE/NOI includes the combination of 1) expenses from loan interest and bank fees; 2) expenses or income from losses or gains from remeasuring the value of EUR cash bank balances in the UK, and GBP cash balances in Ireland, in USD terms; and 3) income from rent of underutilized property, investment income and royalties received from licensing the Company&#8217;s technology. Negative NOE is NOI. &nbsp;Net NOI in 3Q 2021 was $59 compared to $1 NOI in 3Q 2020. Net NOI in 9M 2021 was $130 compared to $126 NOI in 9M 2020. &nbsp;UTMD realized a $13 remeasured currency balance loss in 9M 2021 compared to a $41 gain in 9M 2020, and despite higher cash balances in 2021 compared to 2020, UTMD received $32 less in interest income. Those differences were offset by NOI generated in Ireland from renting unused warehouse space to a third party, yielding 9M 2021 NOI slightly higher than in 9M 2020. &nbsp;   &nbsp;</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'>EBITDA is a non-US GAAP metric that measures profitability performance without factoring in effects of financing, accounting decisions regarding non-cash expenses, capital expenditures or tax environments. Excluding the noncash effects of depreciation, amortization of intangible assets and stock option expense, 3Q 2021 consolidated EBT excluding the remeasured bank balance currency gain or loss and interest expense (&#8220;adjusted consolidated EBITDA&#8221;) was $7,024 compared to $5,432 in 3Q 2020. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Adjusted consolidated EBITDA was $19,495 in 9M 2021 compared to $15,004 in 9M 2020. Adjusted consolidated EBITDA for the previous four calendar quarters (TTM) was $25,616 as of September 30, 2021. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Based on the better than previously projected 3Q 2021 operating results, management expects adjusted consolidated EBITDA of more than $26 million for the full year 2021, and $28 million in 2022. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>UTMD&#8217;s adjusted consolidated EBITDA as a percentage of sales was 55.9% in 3Q 2021 compared to 51.8% in 3Q 2020. &nbsp;UTMD&#8217;s adjusted consolidated EBITDA as a percentage of sales was 53.9% in 9M 2021 compared to 49.7% in 9M 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Achieving substantially higher revenues with an expanded GPM while keeping operating expenses about the same obviously had an extremely positive effect on this key profitability metric. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Management believes that this operating performance metric provides meaningful supplemental information to both management and investors and confirms UTMD&#8217;s ongoing excellent financial operating performance, as well as its recovery from 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>UTMD&#8217;s non-US GAAP adjusted consolidated EBITDA is the sum of the elements in the following table, each element of which is a US GAAP number:</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:47.9%><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.48%><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3Q 2021</FONT></P>
</TD><TD valign=top style='width:13.54%;border-right:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3Q 2020</FONT></P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>9M 2021</FONT></P>
</TD><TD valign=top style=width:13.54%><P align=center style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>9M 2020</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:47.9%><P style='font:11pt Times New Roman;margin:0'>EBT</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>5,157</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>3,588</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>13,880</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.54%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>9,553&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:47.9%><P style='font:11pt Times New Roman;margin:0'>Depreciation Expense</P>
</TD><TD valign=top style=width:11.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>157</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>160</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>483</KBD>&nbsp;</P>
</TD><TD valign=top style=width:13.54%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>495&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:47.9%><P style='font:11pt Times New Roman;margin:0'>Femcare IIA Amortization Expense</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>548</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>517</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>1,653</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.54%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>1,523&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:47.9%><P style='font:11pt Times New Roman;margin:0'>CSI IIA Amortization Expense</P>
</TD><TD valign=top style=width:11.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>1,105</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>1,105</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>3,316</KBD>&nbsp;</P>
</TD><TD valign=top style=width:13.54%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>3,316&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:47.9%><P style='font:11pt Times New Roman;margin:0'>Other Non-Cash Amortization Expense</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>9</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>12</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>27</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.54%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>37&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:47.9%><P style='font:11pt Times New Roman;margin:0'>Stock Option Compensation Expense</P>
</TD><TD valign=top style=width:11.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>41</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>49</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>123</KBD>&nbsp;</P>
</TD><TD valign=top style=width:13.54%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>121&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:47.9%><P style='font:11pt Times New Roman;margin:0'>Interest Expense</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:11.48%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>-</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>-</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>-</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:13.54%><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>-&#160;</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style='width:47.9%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'>Remeasured Foreign Currency Balances</P>
</TD><TD valign=top style='width:11.48%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>7</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>2</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-left:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>13</KBD>&nbsp;</P>
</TD><TD valign=top style='width:13.54%;border-bottom:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>(41)</KBD>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:47.9%;border-top:0.5pt solid #000000'><P align=right style='font:11pt Times New Roman;margin:0'>UTMD non-US GAAP EBITDA:</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:11.48%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:47pt'>7,024</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>5,433</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-top:0.5pt solid #000000;border-left:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>19,495</KBD>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:13.54%;border-top:0.5pt solid #000000'><P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:7pt'>$</KBD><KBD style='position:absolute;text-align:right;font:11pt Times New Roman;width:56pt'>15,004&#160;</KBD>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Note</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>All UTMD income statement measures from GP through EBT (and including non-US GAAP adjusted consolidated EBITDA above) for both 2021 and 2020 time periods were unaffected by the enacted changes in the UK corporate income tax rate.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Net Income (NI)</FONT> </P>
<P style='font:11pt Times New Roman;margin:0'>NI in 3Q 2021 of $4,206 (33.5% of sales) was 43.4% higher than NI of $2,933 (28.0% of sales) in 3Q 2020. US GAAP NI in 9M 2021 of $10,656 (29.5% of sales) was 44.3% higher than the US GAAP NI of $7,386 (24.5% of sales) in 9M 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>NI per US GAAP in both 9M periods was affected by an additional tax provision expense required to be recorded in the quarter in which a tax change is enacted, as a result of an adjustment to UTMD&#8217;s deferred tax liability (DTL). &nbsp;The DTL results from the tax effect of not being able to deduct remaining future amortization expense of Femcare IIA. &nbsp;In 2Q 2020, because the UK reset its corporate tax rate from 17% </P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'><FONT style=font-size:11pt>to 19% going forward, it caused UTMD to have to book an additional $225 in income taxes that represented the additional tax which would be paid in the UK over the remaining six year life of the 2011 Femcare acquisition IIA, based on a 19% rate. In 2Q 2021, because the UK reset its corporate tax rate from 19% to 25% beginning with 2Q 2023, it caused UTMD to have to book an additional $390 in its 2Q 2021 income tax provision that represents the additional tax which will be paid in the UK over the then remaining five year life of the 2011 Femcare acquisition IIA. Excluding the $390 DTL increase in 2Q 2021 and the $225 DTL increase in 2Q 2020, both of which reduced 9M NI by those same amounts, 9M 2021 non-US GAAP NI was $11,047 (30.6% of sales), 45.1% higher than 9M 2020 non-US GAAP NI of $7,611 (25.2% of sales). </FONT></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The average consolidated income tax provisions (as a % of the same period EBT) per US GAAP in 3Q 2021 and 3Q 2020 were 18.4% and 18.3% respectively, and were 23.2% and 22.7% in 9M 2021 and 9M 2020 respectively. As the 9M tax rates for both 2021 and 2020 periods are not directly related to EBT generated in the same periods, UTMD provides the following tax rates excluding the 2Q 2021 $390 tax provision adjustment and the 2Q 2020 $225 income tax provision adjustment: The resulting non-GAAP income tax provision rates were 20.4% for 9M 2021 and 20.3% for 9M 2020. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The consolidated income tax provision rate varies as the mix in taxable income among U.S. and foreign subsidiaries with differing income tax rates differs from period to period. UTMD has consistently paid millions of dollars in income taxes annually. The basic corporate income tax rates in each of the sovereignties were the same as in the prior year. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Earnings per share (EPS)</FONT>. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Diluted EPS in 3Q 2021 were $1.150 compared to $0.803 in 3Q 2020, a 43.2% increase. &nbsp;US GAAP diluted EPS in 9M 2021 were $2.915 compared to $2.008 in 9M 2020, a 45.2% increase. &nbsp;Excluding the &#8220;one-time&#8221; income tax provision increases due to the DTL adjustments, non-US GAAP diluted EPS in 9M 2021 were $3.021 compared to $2.069 in 9M 2020, a 46.0% increase. The increases in EPS were substantial as a result of the improvement in operating results. Diluted shares were 3,657,733 in 3Q 2021 compared to 3,653,500 in 3Q 2020. &nbsp;The higher diluted shares in 3Q 2021 were the result of employee options exercised, offset by a slightly lower dilution factor for unexercised options. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The number of shares used for calculating 3Q 2021 EPS was higher than September 30, 2021 outstanding shares because of a time-weighted calculation of average outstanding shares plus dilution from unexercised employee and director options. Outstanding shares at the end of 3Q 2021 were 3,648,984 compared to 3,643,035 at the end of calendar year 2020. The difference was due to 5,949 shares in employee option exercises during 9M 2021. For comparison, outstanding shares were 3,640,371 at the end of 3Q 2020. The total number of outstanding unexercised employee and outside director options at September 30, 2021 was 59,869 at an average exercise price of $68.74, including shares awarded but not yet vested. &nbsp;This compares to 71,700 unexercised option shares at the end of 3Q 2020 at an average exercise price of $65.80/ share, including shares awarded but not vested. </P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>The number of shares added as a dilution factor for 3Q 2021 was 10,933 compared to 11,130 in 3Q 2020. The number of shares added as a dilution factor for 9M 2021 was 10,685 compared to 14,514 in 9M 2020. In March 2020, 26,300 option shares were awarded to 48 employees at an exercise price of $77.05 per share. No options have been awarded to date in 2021. &nbsp;UTMD paid $1,039 ($0.285/share) in dividends to stockholders in 3Q 2021 compared to $1,020 ($0.280/ share) paid in 3Q 2020. Dividends paid to stockholders during 3Q 2021 were 25% of  NI. UTMD paid $3,116 ($0.285/share) in dividends to stockholders in 9M 2021 compared to $3,097 ($0.280/ share) paid in 9M 2020. The increase in the per share dividend was partially offset by share repurchases in 2020. Dividends paid to stockholders during 9M 2021 were 28% of non-US GAAP NI.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P style='font:11pt Times New Roman;margin:0'>In March 2020, UTMD repurchased 80,000 of its shares in the open market at $80.32/ share. In September 2020, UTMD repurchased 7,000 shares at $78.67/ share. &nbsp;No shares have been repurchased to date in 2021. The Company retains the strong desire and financial ability for repurchasing its shares at a price it believes is attractive for remaining stockholders. UTMD&#8217;s closing share price at the end of 3Q 2021 was $92.84, up from the closing price of $85.04 at the end of 2Q 2021, and the closing price of $84.30 at the end of 2020. &nbsp;&nbsp;&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Balance Sheet</FONT>.</P>
<P style='font:11pt Times New Roman;margin:0'>At September 30, 2021 compared to the end of 2020, UTMD&#8217;s cash and investments increased $12.7 million to $64.3 million primarily as a result of operating EBITDA less a $3.1 million payment of cash dividends to stockholders, plus some changes in working capital including increases in both accounts receivable from the higher sales activity and current liabilities from higher production activity. At September 30, 2021, Net Intangible Assets decreased to 27.5% of total consolidated assets from 34.1% on December 31, 2020 despite a weaker USD which raises the USD value of Femcare&#8217;s GBP IIA. &nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Financial ratios as of September 30, 2021 which may be of interest to stockholders follow:</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:0pt'>1)</KBD><KBD style=margin-left:36pt></KBD>Current Ratio = 15.1&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:0pt'>2)</KBD><KBD style=margin-left:36pt></KBD>Days in Trade Receivables (based on 3Q 2021 sales activity) = 34.5&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:0pt'>3)</KBD><KBD style=margin-left:36pt></KBD>Average Inventory Turns (based on 3Q 2021 CGS) = 2.9&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'><KBD style='position:absolute;font:11pt Times New Roman;margin-left:0pt'>4)</KBD><KBD style=margin-left:36pt></KBD>2021 YTD ROE (before dividends) = 14%&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Investors are cautioned that this press release contains forward looking statements and that actual events may differ from those projected. &nbsp;Risk factors that could cause results to differ materially from those projected include global economic conditions, market acceptance of products, regulatory approvals of products, regulatory intervention in current operations, government intervention in healthcare in general, tax reforms, the Company&#8217;s ability to efficiently manufacture, market and sell products, cybersecurity and foreign currency exchange rates, among other factors that have been and will be outlined in UTMD&#8217;s public disclosure filings with the SEC. &nbsp;UTMD&#8217;s 3Q 2021 SEC Form 10-Q will be filed on or before November 15, 2021, and can be accessed on <FONT style='color:#0000FF;border-bottom:1px solid #0000FF'><I>www.utahmed.com</I></FONT>.</P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0'>Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over one hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. &nbsp;For more information about Utah Medical Products, Inc., visit UTMD&#8217;s website at<B><I> </I></B><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'><I>www.utahmed.com</I></FONT>.</P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'><P align=center style='font:11pt Times New Roman;margin:0'><FONT style=font-size:13pt><B>Utah Medical Products, Inc.</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>INCOME STATEMENT, Third Quarter (three months ended September 30)</P>
<P style='font:10pt Times New Roman;margin:0'>(in thousands except earnings per share):</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:32.64%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.7%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3Q 2021</FONT></P>
</TD><TD valign=top style=width:16.36%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3Q 2020</FONT></P>
</TD><TD valign=top style=width:17.12%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Percent Change</FONT></P>
</TD><TD valign=top style=width:18.18%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3Q 2019</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:32.64%><P style='font:10pt Times New Roman;margin:0'>Net Sales</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.7%><P align=right style='font:10pt Times New Roman;margin:0'>$ 12,572</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.36%><P align=right style='font:10pt Times New Roman;margin:0'>$10,479</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:17.12%><P align=center style='font:10pt Times New Roman;margin:0'>20.0%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:18.18%><P align=right style='font:10pt Times New Roman;margin:0'>$ 12,494</P>
</TD></TR>
<TR><TD valign=top style=width:32.64%><P style='font:10pt Times New Roman;margin:0'>Gross Profit</P>
</TD><TD valign=top style=width:15.7%><P align=right style='font:10pt Times New Roman;margin:0'>8,073</P>
</TD><TD valign=top style=width:16.36%><P align=right style='font:10pt Times New Roman;margin:0'>6,497</P>
</TD><TD valign=top style=width:17.12%><P align=center style='font:10pt Times New Roman;margin:0'>24.3%</P>
</TD><TD valign=top style=width:18.18%><P align=right style='font:10pt Times New Roman;margin:0'>7,379</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:32.64%><P style='font:10pt Times New Roman;margin:0'>Operating Income</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.7%><P align=right style='font:10pt Times New Roman;margin:0'>5,098</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.36%><P align=right style='font:10pt Times New Roman;margin:0'>3,588</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:17.12%><P align=center style='font:10pt Times New Roman;margin:0'>42.1%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:18.18%><P align=right style='font:10pt Times New Roman;margin:0'>4,371</P>
</TD></TR>
<TR><TD valign=top style='width:32.64%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Income Before Tax</P>
</TD><TD valign=top style='width:15.7%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>5,157</P>
</TD><TD valign=top style='width:16.36%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,588</P>
</TD><TD valign=top style='width:17.12%;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>43.7%</P>
</TD><TD valign=top style='width:18.18%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,448</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:32.64%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Net Income (US GAAP)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.7%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>4,206</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.36%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>2,933</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.12%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>43.4%</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:18.18%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,705</P>
</TD></TR>
<TR><TD valign=top style='width:32.64%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Earnings Per Share (US GAAP)</P>
</TD><TD valign=top style='width:15.7%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>$1.150</P>
</TD><TD valign=top style='width:16.36%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>$ .803</P>
</TD><TD valign=top style='width:17.12%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>43.2%</P>
</TD><TD valign=top style='width:18.18%;border-top:0.5pt solid #000000;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>$ .991</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:32.64%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Shares Outstanding (diluted)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:15.7%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,658</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.36%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,654</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.12%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:18.18%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,737</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>INCOME STATEMENT, First Nine Months (nine months ended September 30)</P>
<P style='font:10pt Times New Roman;margin:0'>(in thousands except earnings per share): </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:31.08%><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:16.94%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>9M 2021</FONT></P>
</TD><TD valign=top style=width:16.64%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>9M 2020</FONT></P>
</TD><TD valign=top style=width:17.68%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Percent Change</FONT></P>
</TD><TD valign=top style=width:17.68%><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>9M 2019</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:31.08%><P style='font:10pt Times New Roman;margin:0'>Net Sales</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.94%><P align=right style='font:10pt Times New Roman;margin:0'>$ 36,140</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P align=right style='font:10pt Times New Roman;margin:0'>$ 30,168</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:17.68%><P align=center style='font:10pt Times New Roman;margin:0'>19.8%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:17.68%><P align=right style='font:10pt Times New Roman;margin:0'>$ 35,073</P>
</TD></TR>
<TR><TD valign=top style=width:31.08%><P style='font:10pt Times New Roman;margin:0'>Gross Profit</P>
</TD><TD valign=top style=width:16.94%><P align=right style='font:10pt Times New Roman;margin:0'>22,804</P>
</TD><TD valign=top style=width:16.64%><P align=right style='font:10pt Times New Roman;margin:0'>18,283</P>
</TD><TD valign=top style=width:17.68%><P align=center style='font:10pt Times New Roman;margin:0'>24.7%</P>
</TD><TD valign=top style=width:17.68%><P align=right style='font:10pt Times New Roman;margin:0'>21,652</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:31.08%><P style='font:10pt Times New Roman;margin:0'>Operating Income</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.94%><P align=right style='font:10pt Times New Roman;margin:0'>13,750</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:16.64%><P align=right style='font:10pt Times New Roman;margin:0'>9,428</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:17.68%><P align=center style='font:10pt Times New Roman;margin:0'>45.8%</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:17.68%><P align=right style='font:10pt Times New Roman;margin:0'>12,954</P>
</TD></TR>
<TR><TD valign=top style='width:31.08%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Income Before Tax</P>
</TD><TD valign=top style='width:16.94%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>13,880</P>
</TD><TD valign=top style='width:16.64%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>9,553</P>
</TD><TD valign=top style='width:17.68%;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>45.3%</P>
</TD><TD valign=top style='width:17.68%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>13,150</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:31.08%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>Net Income before DTL adjust</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.94%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>11,047</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.64%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>7,611</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.68%;border-top:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><I>45.1%</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.68%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>10,369</I></P>
</TD></TR>
<TR><TD valign=top style='width:31.08%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Net Income (US GAAP)</P>
</TD><TD valign=top style='width:16.94%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>10,656</P>
</TD><TD valign=top style='width:16.64%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>7,386</P>
</TD><TD valign=top style='width:17.68%;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>44.3%</P>
</TD><TD valign=top style='width:17.68%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>10,369</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:31.08%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'><I>EPS before DTL adjustment</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.94%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$ 3.021</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.64%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$ 2.069</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.68%;border-top:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><I>46.0%</I></P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.68%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><I>$ 2.774</I></P>
</TD></TR>
<TR><TD valign=top style='width:31.08%;border-bottom:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>EPS (US GAAP)</P>
</TD><TD valign=top style='width:16.94%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>$ 2.915</P>
</TD><TD valign=top style='width:16.64%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>$ 2.008</P>
</TD><TD valign=top style='width:17.68%;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>45.2%</P>
</TD><TD valign=top style='width:17.68%;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>$ 2.774</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style='width:31.08%;border-top:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0'>Shares Outstanding (diluted)</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.94%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,656</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:16.64%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,678</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.68%;border-top:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style='width:17.68%;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>3,738</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>BALANCE SHEET</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:100%><TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>(in thousands)</P>
</TD><TD valign=top style=width:14.32%><P align=center style='font:10pt Times New Roman;margin:0'>(unaudited)</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>SEP 30, 2021</FONT></P>
</TD><TD valign=top style=width:15.12%><P align=center style='font:10pt Times New Roman;margin:0'>(unaudited)</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>JUN 30, 2021</FONT></P>
</TD><TD valign=top style=width:14.58%><P align=center style='font:10pt Times New Roman;margin:0'>(audited)</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>DEC 31, 2020</FONT></P>
</TD><TD valign=top style=width:14.92%><P align=center style='font:10pt Times New Roman;margin:0'>(unaudited)</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>SEP 30, 2020</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Assets</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Cash &amp; Investments</P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>$64,321</P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>$59,506</P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>$51,590</P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>$46,294</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Accounts &amp; Other Receivables, Net</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>4,853</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>4,606</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>4,104</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>4,277</P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Inventories</P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>6,299</P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>6,118</P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>6,222</P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>6,304</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Other Current Assets</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>373</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>357</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>346</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>385</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;Total Current Assets</P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>75,846</P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>70,587</P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>62,262</P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>57,260</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>Property &amp; Equipment, Net</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>10,932</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>11,168</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>11,326</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>11,036</P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>Intangible Assets, Net</P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>32,974</FONT></P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>35,039</FONT></P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>38,157</FONT></P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>38,776</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Assets</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>$119,752</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>$116,794</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>$111,745</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>$107,072</P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>Liabilities &amp; Stockholders&#8217; Equity</FONT></P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>Accounts Payable</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>$ &nbsp;1,026</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>$ &nbsp;1,186</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>$ &nbsp;&nbsp;788</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>$ &nbsp;&nbsp;651</P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>REPAT Tax Payable</P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>237</P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>245</P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>79</P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0;margin-left:18pt'>79 </P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>Other Accrued Liabilities</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3,752</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>3,000</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2,924</FONT></P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>2,897</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;Total Current Liabilities</P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;$5,015</P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;$4,431</P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;$3,791</P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'> &nbsp;$3,627</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>Deferred Tax Liability &#8211;&nbsp;Intangible Assets</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>2,196</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>2,355</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>2,151</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>2,132</P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>Long Term Lease Liability </P>
<P style='font:10pt Times New Roman;margin:0'>Long Term REPAT Tax Payable</P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>343</P>
<P align=right style='font:10pt Times New Roman;margin:0'>1,810</P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>322</P>
<P align=right style='font:10pt Times New Roman;margin:0'>1,835</P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>335</P>
<P align=right style='font:10pt Times New Roman;margin:0'>1,995</P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0;margin-left:36pt'>346</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:36pt'>1,995</P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>Deferred Revenue and Income Taxes</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>408</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>486</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>651</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>557</P>
</TD></TR>
<TR><TD valign=top style=width:41.04%><P style='font:10pt Times New Roman;margin:0'>Stockholders&#8217; Equity</P>
</TD><TD valign=top style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>109,980</FONT></P>
</TD><TD valign=top style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>107,365</FONT></P>
</TD><TD valign=top style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>102,822</FONT></P>
</TD><TD valign=top style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'>98,415</FONT></P>
</TD></TR>
<TR><TD valign=top bgcolor=#CCEEFF style=width:41.04%><P style='font:10pt Times New Roman;margin:0'> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities &amp; Stockholders&#8217; Equity</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.32%><P align=right style='font:10pt Times New Roman;margin:0'>$119,752</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:15.12%><P align=right style='font:10pt Times New Roman;margin:0'>$116,794</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.58%><P align=right style='font:10pt Times New Roman;margin:0'>$111,745</P>
</TD><TD valign=top bgcolor=#CCEEFF style=width:14.92%><P align=right style='font:10pt Times New Roman;margin:0'>$107,072</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:14pt 0 0 0'></DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>utmd-20211026_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VFXC9N1U]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20211026"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
	<link:roleRef roleURI="http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="utmd-20211026.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:definitionLink xlink:type="extended" xlink:role="http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>utmd-20211026_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VFXC9N1U]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20211026"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
	<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince' xlink:label='dei_EntityAddressStateOrProvince'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressStateOrProvince' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, State or Province</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressStateOrProvince' xlink:to='lab_dei_EntityAddressStateOrProvince'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFilerCategory' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Filer Category</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFilerCategory' xlink:to='lab_dei_EntityFilerCategory'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCommonStockSharesOutstanding' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Number of common stock shares outstanding</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCommonStockSharesOutstanding' xlink:to='lab_dei_EntityCommonStockSharesOutstanding'/>
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:label xlink:type='resource' xlink:label='lab_us-gaap_TextBlockAbstract' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Details</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='us-gaap_TextBlockAbstract' xlink:to='lab_us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode' xlink:label='dei_EntityAddressPostalZipCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressPostalZipCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, Postal Zip Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressPostalZipCode' xlink:to='lab_dei_EntityAddressPostalZipCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_TradingSymbol' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Symbol</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_TradingSymbol' xlink:to='lab_dei_TradingSymbol'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode' xlink:label='dei_CityAreaCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CityAreaCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>City Area Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CityAreaCode' xlink:to='lab_dei_CityAreaCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber' xlink:label='dei_EntityFileNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityFileNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity File Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityFileNumber' xlink:to='lab_dei_EntityFileNumber'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer' xlink:label='dei_PreCommencementIssuerTenderOffer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_PreCommencementIssuerTenderOffer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Pre-commencement Issuer Tender Offer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_PreCommencementIssuerTenderOffer' xlink:to='lab_dei_PreCommencementIssuerTenderOffer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications' xlink:label='dei_WrittenCommunications'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_WrittenCommunications' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Written Communications</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_WrittenCommunications' xlink:to='lab_dei_WrittenCommunications'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown' xlink:label='dei_EntityAddressCityOrTown'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressCityOrTown' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, City or Town</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressCityOrTown' xlink:to='lab_dei_EntityAddressCityOrTown'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode' xlink:label='dei_EntityIncorporationStateCountryCode'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityIncorporationStateCountryCode' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Incorporation, State or Country Code</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityIncorporationStateCountryCode' xlink:to='lab_dei_EntityIncorporationStateCountryCode'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial' xlink:label='dei_SolicitingMaterial'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_SolicitingMaterial' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Soliciting Material</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_SolicitingMaterial' xlink:to='lab_dei_SolicitingMaterial'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1' xlink:label='dei_EntityAddressAddressLine1'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityAddressAddressLine1' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Entity Address, Address Line One</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityAddressAddressLine1' xlink:to='lab_dei_EntityAddressAddressLine1'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityVoluntaryFilers' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Voluntary filer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityVoluntaryFilers' xlink:to='lab_dei_EntityVoluntaryFilers'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityPublicFloat' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Public Float</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityPublicFloat' xlink:to='lab_dei_EntityPublicFloat'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber' xlink:label='dei_LocalPhoneNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_LocalPhoneNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Local Phone Number</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_LocalPhoneNumber' xlink:to='lab_dei_LocalPhoneNumber'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription' xlink:label='dei_AmendmentDescription'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentDescription' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Description</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentDescription' xlink:to='lab_dei_AmendmentDescription'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCurrentReportingStatus' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Current with reporting</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCurrentReportingStatus' xlink:to='lab_dei_EntityCurrentReportingStatus'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber' xlink:label='dei_EntityTaxIdentificationNumber'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityTaxIdentificationNumber' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Tax Identification Number (TIN)</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityTaxIdentificationNumber' xlink:to='lab_dei_EntityTaxIdentificationNumber'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentType' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>SEC Form</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentType' xlink:to='lab_dei_DocumentType'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_AmendmentFlag' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Amendment Flag</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_AmendmentFlag' xlink:to='lab_dei_AmendmentFlag'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod' xlink:label='dei_EntityExTransitionPeriod'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityExTransitionPeriod' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Ex Transition Period</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityExTransitionPeriod' xlink:to='lab_dei_EntityExTransitionPeriod'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityWellKnownSeasonedIssuer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Well-known Seasoned Issuer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityWellKnownSeasonedIssuer' xlink:to='lab_dei_EntityWellKnownSeasonedIssuer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer' xlink:label='dei_PreCommencementTenderOffer'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_PreCommencementTenderOffer' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Pre-commencement Tender Offer</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_PreCommencementTenderOffer' xlink:to='lab_dei_PreCommencementTenderOffer'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness' xlink:label='dei_EntitySmallBusiness'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntitySmallBusiness' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Small Business</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntitySmallBusiness' xlink:to='lab_dei_EntitySmallBusiness'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityRegistrantName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Registrant Name</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityRegistrantName' xlink:to='lab_dei_EntityRegistrantName'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName' xlink:label='dei_SecurityExchangeName'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_SecurityExchangeName' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Trading Exchange</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_SecurityExchangeName' xlink:to='lab_dei_SecurityExchangeName'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityCentralIndexKey' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Registrant CIK</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityCentralIndexKey' xlink:to='lab_dei_EntityCentralIndexKey'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany' xlink:label='dei_EntityShellCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityShellCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Shell Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityShellCompany' xlink:to='lab_dei_EntityShellCompany'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent' xlink:label='dei_EntityInteractiveDataCurrent'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityInteractiveDataCurrent' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Interactive Data Current</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityInteractiveDataCurrent' xlink:to='lab_dei_EntityInteractiveDataCurrent'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_DocumentPeriodEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Period End date</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_DocumentPeriodEndDate' xlink:to='lab_dei_DocumentPeriodEndDate'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_CurrentFiscalYearEndDate' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Fiscal Year End</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_CurrentFiscalYearEndDate' xlink:to='lab_dei_CurrentFiscalYearEndDate'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany' xlink:label='dei_EntityEmergingGrowthCompany'/>
		<link:label xlink:type='resource' xlink:label='lab_dei_EntityEmergingGrowthCompany' xlink:role='http://www.xbrl.org/2003/role/label' xml:lang='en-US'>Emerging Growth Company</link:label>
		<link:labelArc order='1.0' xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/concept-label' xlink:from='dei_EntityEmergingGrowthCompany' xlink:to='lab_dei_EntityEmergingGrowthCompany'/>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>utmd-20211026_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VFXC9N1U]. www.edgarsuite.com -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase"
		xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
		xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
		xmlns:fil="http://utahmed.com/20211026"
		xmlns:link="http://www.xbrl.org/2003/linkbase"
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
		xmlns:xbrli="http://www.xbrl.org/2003/instance">
	<link:roleRef roleURI="http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation" xlink:type="simple" xlink:href="utmd-20211026.xsd#idr_DocumentDocumentAndEntityInformation"/>
	<link:presentationLink xlink:type="extended" xlink:role="http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation">
		<link:loc xlink:type='locator' xlink:href='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract' xlink:label='us-gaap_TextBlockAbstract'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey' xlink:label='dei_EntityCentralIndexKey'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCentralIndexKey' use='optional' order='1.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate' xlink:label='dei_CurrentFiscalYearEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_CurrentFiscalYearEndDate' use='optional' order='2.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName' xlink:label='dei_EntityRegistrantName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityRegistrantName' use='optional' order='3.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType' xlink:label='dei_DocumentType'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentType' use='optional' order='4.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate' xlink:label='dei_DocumentPeriodEndDate'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_DocumentPeriodEndDate' use='optional' order='5.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol' xlink:label='dei_TradingSymbol'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_TradingSymbol' use='optional' order='6.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName' xlink:label='dei_SecurityExchangeName'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_SecurityExchangeName' use='optional' order='7.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber' xlink:label='dei_EntityTaxIdentificationNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityTaxIdentificationNumber' use='optional' order='8.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding' xlink:label='dei_EntityCommonStockSharesOutstanding'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCommonStockSharesOutstanding' use='optional' order='9.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat' xlink:label='dei_EntityPublicFloat'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityPublicFloat' use='optional' order='10.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory' xlink:label='dei_EntityFilerCategory'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityFilerCategory' use='optional' order='11.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus' xlink:label='dei_EntityCurrentReportingStatus'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityCurrentReportingStatus' use='optional' order='12.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent' xlink:label='dei_EntityInteractiveDataCurrent'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityInteractiveDataCurrent' use='optional' order='13.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers' xlink:label='dei_EntityVoluntaryFilers'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityVoluntaryFilers' use='optional' order='14.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer' xlink:label='dei_EntityWellKnownSeasonedIssuer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityWellKnownSeasonedIssuer' use='optional' order='15.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany' xlink:label='dei_EntityShellCompany'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityShellCompany' use='optional' order='16.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness' xlink:label='dei_EntitySmallBusiness'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntitySmallBusiness' use='optional' order='17.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany' xlink:label='dei_EntityEmergingGrowthCompany'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityEmergingGrowthCompany' use='optional' order='18.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod' xlink:label='dei_EntityExTransitionPeriod'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityExTransitionPeriod' use='optional' order='19.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription' xlink:label='dei_AmendmentDescription'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_AmendmentDescription' use='optional' order='20.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode' xlink:label='dei_EntityIncorporationStateCountryCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityIncorporationStateCountryCode' use='optional' order='21.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber' xlink:label='dei_EntityFileNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityFileNumber' use='optional' order='22.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1' xlink:label='dei_EntityAddressAddressLine1'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressAddressLine1' use='optional' order='23.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown' xlink:label='dei_EntityAddressCityOrTown'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressCityOrTown' use='optional' order='24.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince' xlink:label='dei_EntityAddressStateOrProvince'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressStateOrProvince' use='optional' order='25.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode' xlink:label='dei_EntityAddressPostalZipCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_EntityAddressPostalZipCode' use='optional' order='26.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode' xlink:label='dei_CityAreaCode'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_CityAreaCode' use='optional' order='27.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber' xlink:label='dei_LocalPhoneNumber'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_LocalPhoneNumber' use='optional' order='28.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications' xlink:label='dei_WrittenCommunications'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_WrittenCommunications' use='optional' order='29.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial' xlink:label='dei_SolicitingMaterial'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_SolicitingMaterial' use='optional' order='30.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer' xlink:label='dei_PreCommencementTenderOffer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_PreCommencementTenderOffer' use='optional' order='31.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer' xlink:label='dei_PreCommencementIssuerTenderOffer'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_PreCommencementIssuerTenderOffer' use='optional' order='32.0'/>
		<link:loc xlink:type='locator' xlink:href='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag' xlink:label='dei_AmendmentFlag'/>
		<link:presentationArc xlink:type='arc' xlink:arcrole='http://www.xbrl.org/2003/arcrole/parent-child' xlink:from='us-gaap_TextBlockAbstract' xlink:to='dei_AmendmentFlag' use='optional' order='33.0'/>
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>utmd-20211026.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='iso-8859-1'?>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2021 [PPXK5GW761L0VFXC9N1U]. www.edgarsuite.com -->
<schema xmlns='http://www.w3.org/2001/XMLSchema' xmlns:us-gaap='http://fasb.org/us-gaap/2020-01-31' xmlns:fil='http://utahmed.com/20211026' xmlns:dei='http://xbrl.sec.gov/dei/2020-01-31' xmlns:xlink='http://www.w3.org/1999/xlink' xmlns:xbrldt='http://xbrl.org/2005/xbrldt' targetNamespace='http://utahmed.com/20211026' xmlns:link='http://www.xbrl.org/2003/linkbase' xmlns:xbrli='http://www.xbrl.org/2003/instance' elementFormDefault='qualified' attributeFormDefault='unqualified'>
	<annotation>
		<appinfo>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20211026_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20211026_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:linkbaseRef xlink:type="simple" xlink:href="utmd-20211026_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
			<link:roleType roleURI="http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation" id="idr_DocumentDocumentAndEntityInformation">
				<link:definition>000010 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
			</link:roleType>
		</appinfo>
	</annotation>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/numeric'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2005/xbrldt-2005.xsd' namespace='http://xbrl.org/2005/xbrldt'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd' namespace='http://www.xbrl.org/dtr/type/non-numeric'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import schemaLocation='http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd' namespace='http://www.xbrl.org/2003/instance'/>
	<import namespace='http://fasb.org/us-gaap/2020-01-31' schemaLocation='http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd' />
	<import namespace='http://xbrl.sec.gov/dei/2020-01-31' schemaLocation='https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd' />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>utmd-20211026_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="utmd-20211026.xsd" xlink:type="simple"/>
    <context id="D211026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000706698</identifier>
        </entity>
        <period>
            <startDate>2021-10-26</startDate>
            <endDate>2021-10-26</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="D211026" id="fact1">0000706698</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="D211026" id="fact2">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="D211026">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="D211026">2021-10-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="D211026">UTAH MEDICAL PRODUCTS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="D211026">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="D211026">000-12575</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="D211026">87-0342734</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="D211026">7043 South 300 West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="D211026">Midvale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="D211026">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="D211026">84047</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="D211026">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="D211026">566-1200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="D211026">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="D211026">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="D211026">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="D211026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="D211026">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140017866857176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 26, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Registrant CIK</a></td>
<td class="text">0000706698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">UTAH MEDICAL PRODUCTS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">SEC Form</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Period End date</a></td>
<td class="text">Oct. 26,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Tax Identification Number (TIN)</a></td>
<td class="text">87-0342734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-12575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7043 South 300 West<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Midvale<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">566-1200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
M8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'=R>9KEMWDOSA
MR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB
M0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>
M@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&
M8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%
M=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM(+#5
M2?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS8]$7
M>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;
MIJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=Y
MYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNH
MR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \
M& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH
M=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z
M@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^
M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 27A:4YE<G",0!@  G"<  !,
M             ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" !)>%I3/02<J<P#  !+#@  &               @($-"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 27A:4Y^@&_"Q @  X@P   T
M             ( !#PP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !)>%I3
MEXJ[',     3 @  "P              @ 'K#@  7W)E;',O+G)E;'-02P$"
M% ,4    " !)>%I3'#AEZC\!   \ @  #P              @ '4#P  >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ 27A:4R0>FZ*M    ^ $  !H
M         ( !0!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ 27A:4V60>9(9 0  SP,  !,              ( !)1(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ;Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="utmd-20211026.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="utmd-20211026.htm">utmd-20211026.htm</File>
    <File>utah_ex99z1.htm</File>
    <File>utmd-20211026.xsd</File>
    <File>utmd-20211026_def.xml</File>
    <File>utmd-20211026_lab.xml</File>
    <File>utmd-20211026_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "utmd-20211026.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "utmd-20211026_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "utmd-20211026.htm"
     ]
    },
    "labelLink": {
     "local": [
      "utmd-20211026_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "utmd-20211026_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "utmd-20211026.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 34,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fil",
   "nsuri": "http://utahmed.com/20211026",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "utmd-20211026.htm",
      "contextRef": "D211026",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010 - Document - Document and Entity Information",
     "role": "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "utmd-20211026.htm",
      "contextRef": "D211026",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Fiscal Year End"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Period End date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "SEC Form"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Registrant CIK"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Number of common stock shares outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Current with reporting"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Tax Identification Number (TIN)"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Voluntary filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Trading Exchange"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://utahmed.com/20211026/role/idr_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Details"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r4": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r5": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001096906-21-002587-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001096906-21-002587-xbrl.zip
M4$L#!!0    ( $EX6E,I$3J)I$,  $.E @ /    =71A:%]E>#DY>C$N:'1M
M[7UK<]O(L>CW\ROF5N2L5(%@//FP'5?)DNS5R=K66G*RY]ZZ'T!R*"(F 2X
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M:""_0&1&@"YZ?([3R11D**$400@=>&S* ]<?A+"X"%9+KXL]23^-T"FL-XN
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M=L(&,RZJ^*(9O-(?.5@5Q+CG$$  ]M=_$ !4:J2RLS ;?IDX6/LW(;^4",
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M-KH_$0&7CSU+W2(VNBSC]UB?^^9JE8S_- ^E*NR=11EA9X-_HVE[];8Z\Q:
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M4U00J0"Y:'JU$XPYO5G%8:266CN F"'/IT$L<&"Y>DL]PJJ#L=!6:XK9ZB[
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M/+EW5=2TJOD:]@+W$P:$DCIX\9')F$PRD854'?]QDH74A>'Q;[)7/3_>_-/
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M556%>$*LQC:R'2[_OG:6P%)VVZW("^#Q\9EO3B[TKK<\06M0FDG1K_I>O8I
MA)(RL>Q7F9:XW6YUL%^]'I1[;S!&4R5I&@)%BQVZO;D?SG3*#" M([,)%-30
MD*X#X00CR5>I 87&0LAU8&P#7;.+T*O9O=5.L65LT+O1>]2HU]NX46_XZ/MT
M.O_8NO_VX<J?U+_>S4>=S_[##P]M-AL/Z#)063<OE!QA;(D2)GYUW<<BT(#L
M*$+W*[$QJRXA[LQVH1)/JB6Q+9HD%U;*I5*F[6XU.]%OFKG:)_-/DR]A##S
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MDOG'C9X2M$':-FTML%M- OP=U[-Y3'W]]4Z,==GQ'/T-99W8;QH$R#NN:O/
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M   1              "  =%#  !U=&UD+3(P,C$Q,#(V+FAT;5!+ 0(4 Q0
M   ( $EX6E/8@0.YW@,  /&"   1              "  4I2  !U=&UD+3(P
M,C$Q,#(V+GAS9%!+ 0(4 Q0    ( $EX6E/1QC%O%P(  "8'   5
M      "  5=6  !U=&UD+3(P,C$Q,#(V7V1E9BYX;6Q02P$"% ,4    " !)
M>%I3(U/&IB4(  "=3P  %0              @ &A6   =71M9"TR,#(Q,3 R
M-E]L86(N>&UL4$L! A0#%     @ 27A:4\8A_)JL!0  $34  !4
M     ( !^6   '5T;60M,C R,3$P,C9?<')E+GAM;%!+!08     !@ & (0!
(  #89@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
